Atıf İçin Kopyala
ÇİÇİN İ., Oukkal M., Mahfouf H., Mezlini A., Larbaoui B., Ben Ahmed S., ...Daha Fazla
EUROPEAN JOURNAL OF BREAST HEALTH, cilt.18, sa.1, ss.63-73, 2022 (ESCI)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
18
Sayı:
1
-
Basım Tarihi:
2022
-
Doi Numarası:
10.4274/ejbh.galenos.2021.2021-9-9
-
Dergi Adı:
EUROPEAN JOURNAL OF BREAST HEALTH
-
Derginin Tarandığı İndeksler:
Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
-
Sayfa Sayıları:
ss.63-73
-
Anahtar Kelimeler:
subcutaneous, trastuzumab, breast cancer, HER2, patient satisfaction, ADJUVANT CHEMOTHERAPY, FINAL ANALYSIS, SAFETY, TOLERABILITY, EXPERIENCE
-
İstanbul Üniversitesi Adresli:
Evet
Özet
Objective: This study was designed to investigate treatment satisfaction in patients and Health Care Professionals (HCP) and to evaluate the safety and tolerability of subcutaneous (SC) trastuzumab in patients with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer (eBC).